Term Name: varlitinib
Synonyms: AR-00334543, AR00334543, ARRY 334543, ARRY-334543, ARRY-543, ASLAN-001, ASLAN001, N(4)-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-N(6)-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine, varlitinib, varlitinibum
Definition: A member of the class of quinazolines that is quinazoline substituted by {3-chloro-4-[(1,3-thiazol-2-yl)methoxy]phenyl}amino and [(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]amino groups at positions 4 and 6, respectively. It is a tyrosine kinase inhibitor of both ErbB-2 (Her-2/neu) and EGFR and has shown significant anti-tumour activity in preclinical models of human breast, lung, and epidermal carcinoma tumours.
Ontology: ChEBI [CHEBI:231356]  ( EBI )

Relationships
is a type of: 1,3-thiazoles aromatic ether monochlorobenzenes oxazoline quinazoline secondary amino compound substituted aniline
has_role: antineoplastic agent apoptosis inducer EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor epidermal growth factor receptor antagonist